Teladoc Health ( NYSE:TDOC – Get Rating ) had its target price decreased by Citigroup from $33.00 to $30.00 in a research note issued to investors on Tuesday morning, Benzinga reports. Citigroup currently has a neutral rating on the health services provider's stock. Other analysts have also recently issued reports about the stock. StockNews.com upgraded shares of Teladoc Health to a sell rating in a research note on Friday, February 24th. JPMorgan Chase & Co. dropped their target price on shares of Teladoc Health from $35.

https://www.dailypolitical.com/2023/03/03/teladoc-health-nysetdoc-given-new-30-00-price-target-at-citigroup.html

#dailypolitical